Last mentioned: Mar 15, 2026
Eventide Rebalancing
Eventide Asset Management reports a reduced but significant stake of $83.65 million in Collegium.
Institutional Reduction
Integrated Quantitative Investments LLC reduces its stock position in COLL.
Truist Analysis
Truist Securities highlights momentum for Jornay PM and a robust pain portfolio.
BDSI Acquisition
Collegium completes the acquisition of BioDelivery Sciences International, adding Belbuca to its portfolio.
Eventide Asset Management LLC has reduced its equity position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional shift comes as the specialty pharmaceutical firm navigates a shifting landscape for chronic pain management and expands into neurology.
CRA International (CRAI) and Collegium Pharmaceutical (COLL) both reported strong Q4 2025 results, highlighting a robust environment for specialized consulting and chronic pain management. While CRAI benefited from record headcount and high utilization in antitrust and litigation, Collegium demonstrated the continued commercial durability of its Belbuca and Xtampza ER franchises.
This page surfaces every story mentioning Collegium Pharmaceutical, Inc. across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Collegium Pharmaceutical, Inc. was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |